Clinical Scorecard: CDC: Measles cases surpass 4,000 in 2026
At a Glance
Category
Detail
Condition
Measles
Key Mechanisms
The article reports measles surveillance and MMR vaccine effectiveness; it does not describe disease mechanisms.
Target Population
People with confirmed measles cases reported in the United States in 2026, including children and adults.
Care Setting
US public health surveillance; the reported figures include cases reported by jurisdictions and international visitors.
Key Highlights
The CDC reported 4,080 confirmed US measles cases through October 8, 2026, including 414 hospitalizations and 2 deaths; totals are preliminary and subject to revision.
Of confirmed cases, 96% were outbreak-associated, and 95% occurred among people who were unvaccinated or whose vaccination status was unknown.
Adults aged 20 years and older accounted for 40% of cases; children aged 5 to 19 years accounted for 42%, and children younger than 5 years for 17%.
MMR coverage among US kindergartners declined from 95.2% in 2019–2020 to 92.4% in 2025–2026; the CDC estimated approximately 280,000 kindergartners were at risk.
The CDC reported MMR vaccine effectiveness of 97% after 2 doses and 93% after 1 dose.
Guideline-Based Recommendations
Diagnosis
The article reports confirmed-case surveillance; probable cases are excluded.
Management
Monitoring & Follow-up
The CDC surveillance total reflects cases reported through October 8, 2026, and remains preliminary and subject to revision.
The CDC defines an outbreak as 3 or more related cases.
Risks
The CDC grouped unvaccinated people with those whose vaccination status was unknown because vaccination documentation may be unavailable; the reported 95% should not be interpreted as confirmed unvaccinated cases alone.
Children younger than 5 years had the highest age-specific hospitalization proportion, at 15% (107 of 710).
The CDC noted that local vaccination coverage varies and that pockets of unvaccinated individuals persist, including in states with high overall coverage.
Patient & Prescribing Data
Confirmed cases included 1,635 adults aged 20 years and older, 1,716 children aged 5 to 19 years, and 710 children younger than 5 years.
The article reports MMR vaccine effectiveness of 97% after 2 doses and 93% after 1 dose. It does not provide treatment or prescribing instructions.
Clinical Best Practices
Interpret the combined unvaccinated-or-unknown vaccination-status category as reported; it does not identify only people confirmed to be unvaccinated.
Account for the preliminary nature of 2026 totals and the exclusion of probable cases when interpreting the surveillance figures.
Consider local variation in vaccination coverage when interpreting national coverage figures.
